News
Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer’s perspective
Authors: B Heeg, J Damen, B Van Hout Published: PharmacoEconomics, 2010 View publication Background A wide variety of oral antiplatelet trials have been carried out, and a large number of cost-effectiveness estimates...
The use of a surgical sealant (CoSeal) in cardiac and vascular reconstructive surgery: an economic analysis
Authors: E Buskens, M J Meijboom, H Kooijman, B A Van Hout Published: Journal of Cardiovascular Surgery (Torino), 2010 View publication Objective We designed a study to estimate the economic impact of...
Bleeding-related complications and readmission rates associated with fibrin sealant use in patients undergoing coronary artery bypass graft surgery in the United States
Authors: Y Wan, S Lim, X Gao, W A Danker, R Kocharian, G Gangoli, A P DeAnglis, J Hart Published: Journal of Cardiothoracic and Vascular Anesthesia, 2016 View publication Objectives To compare...